Literature DB >> 2548009

Poliovirus-associated protein kinase: destabilization of the virus capsid and stimulation of the phosphorylation reaction by Zn2+.

M Ratka1, M Lackmann, C Ueckermann, U Karlins, G Koch.   

Abstract

The previously described poliovirus-associated protein kinase activity phosphorylates viral proteins VP0 and VP2 as well as exogenous proteins in the presence of Mg2+. In this paper, the effect of Zn2+ on the phosphorylation reaction and the stability of the poliovirus capsid has been studied in detail and compared to that of Mg2+. Phosphorylation patterns of viral and other proteins depend on the divalent cation present. In the presence of Zn2+, phosphorylation of capsid proteins VP2 and VP4 is significantly higher while phosphorylation of VP0 and exogenous phosphate acceptor proteins is not detected. Our results indicate the activation of more than one virus-associated protein kinase by Zn2+. The ion-dependent behavior of the enzyme activities is observed independently of whether the virus was obtained from HeLa or green monkey kidney cells. The poliovirus capsid is destabilized by Zn2+. The destabilization leads to a substantially increased permeability of virus particles to ethidium bromide and RNase, concomitant with decreased infectivity of the sample. This alteration of the poliovirus capsid structure is a prerequisite for effective phosphorylation of viral capsid proteins. The increased level of phosphorylation of viral capsid proteins results in further destabilization of the viral capsid. As a result of the conformational changes, poliovirus-associated protein kinase activities dissociate from the virus particle. High-performance liquid chromatography-purified viral protein VP2 is phosphorylated by the released enzymes on serine, threonine, and tyrosine in the presence of Zn2+. We suggest that the destabilizing effect of phosphorylation on the viral capsid plays a role in uncoating of poliovirus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548009      PMCID: PMC250992          DOI: 10.1128/JVI.63.9.3954-3960.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Studies on the in vitro uncoating of poliovirus. I. Characterization of the modifying factor and the modifying reaction.

Authors:  J De Sena; B Mandel
Journal:  Virology       Date:  1976-04       Impact factor: 3.616

2.  Inhibition of uncoating of poliovirus by arildone, a new antiviral drug.

Authors:  J J McSharry; L A Caliguiri; H J Eggers
Journal:  Virology       Date:  1979-09       Impact factor: 3.616

3.  Studies on the in vitro uncoating of poliovirus. II. Characteristics of the membrane-modified particle.

Authors:  J De Sena; B Mandel
Journal:  Virology       Date:  1977-05-15       Impact factor: 3.616

4.  A plasma membrane component able to bind and alter virions of poliovirus type 1: studies on cell-free alteration using a simplified assay.

Authors:  N Guttman; D Baltimore
Journal:  Virology       Date:  1977-10-01       Impact factor: 3.616

5.  Role of the membrane potential in serum-stimulated uptake of amino acid in a diploid human fibroblast.

Authors:  M L Vilereal; J S Cook
Journal:  J Supramol Struct       Date:  1977

6.  An agar cell-suspension plaque assay for isolated viral RNA.

Authors:  G Koch; N Quintrell; J M Bishop
Journal:  Biochem Biophys Res Commun       Date:  1966-08-12       Impact factor: 3.575

7.  Protein kinases associated with the adenovirus single-stranded DNA-binding protein.

Authors:  C Cajean-Feroldi; J Loeb; S Meguenni; M Girard
Journal:  Eur J Biochem       Date:  1981-11

8.  Herpes simplex virus phosphoproteins. II. Characterization of the virion protein kinase and of the polypeptides phosphorylated in the virion.

Authors:  S Lemaster; B Roizman
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

9.  Zn2+ enhances protein tyrosine kinase activity of human platelet membranes.

Authors:  D Findik; P Presek
Journal:  FEBS Lett       Date:  1988-08-01       Impact factor: 4.124

10.  Identification of a protein kinase activity in purified foot- and-mouth disease virus.

Authors:  M J Grubman; B Baxt; J L La Torre; H L Bachrach
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

View more
  7 in total

1.  The correlation between prognosis of HCMV infection and zinc in mature women.

Authors:  Dan Li; Liangzhen Wen; Hui Yuan; Nan Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

2.  Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.

Authors:  Justyna Broniarczyk; Paola Massimi; David Pim; Martina Bergant Marušič; Michael P Myers; Robert L Garcea; Lawrence Banks
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

3.  Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments.

Authors:  U Schubert; K Strebel
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

4.  Additive Effects of Zinc Chloride on the Suppression of Hepatitis A Virus Replication by Interferon in Human Hepatoma Huh7 Cells.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Hiroshi Takahashi; Mariko Fujisawa; Naoki Matsumoto; Hiroaki Okamoto; Mitsuhiko Moriyama
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 5.  Antiviral properties of lactoferrin--a natural immunity molecule.

Authors:  Francesca Berlutti; Fabrizio Pantanella; Tiziana Natalizi; Alessandra Frioni; Rosalba Paesano; Antonella Polimeni; Piera Valenti
Journal:  Molecules       Date:  2011-08-16       Impact factor: 4.411

Review 6.  Venezuelan Equine Encephalitis Virus Capsid-The Clever Caper.

Authors:  Lindsay Lundberg; Brian Carey; Kylene Kehn-Hall
Journal:  Viruses       Date:  2017-09-29       Impact factor: 5.048

7.  Zinc and Copper Ions Differentially Regulate Prion-Like Phase Separation Dynamics of Pan-Virus Nucleocapsid Biomolecular Condensates.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Viruses       Date:  2020-10-18       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.